skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: Elsevier ClinicalKey Journals remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia
Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Prognostic and therapeutic impacts of mutant TP53 variant allelic frequency in newly diagnosed acute myeloid leukemia

Short, Nicholas J. ; Montalban-Bravo, Guillermo ; Hwang, Hyunsoo ; Ning, Jing ; Franquiz, Miguel J. ; Kanagal-Shamanna, Rashmi ; Patel, Keyur P. ; DiNardo, Courtney D. ; Ravandi, Farhad ; Garcia-Manero, Guillermo ; Takahashi, Koichi ; Konopleva, Marina ; Daver, Naval ; Issa, Ghayas C. ; Andreeff, Michael ; Kantarjian, Hagop ; Kadia, Tapan M.

Blood advances, 2020-11, Vol.4 (22), p.5681-5689 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Acute myeloid leukaemia
Acute myeloid leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Acute myeloid leukaemia

Short, Nicholas J ; Rytting, Michael E ; Cortes, Jorge E

The Lancet (British edition), 2018-08, Vol.392 (10147), p.593-606 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
3
Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?
Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Which tyrosine kinase inhibitor should we use to treat Philadelphia chromosome-positive acute lymphoblastic leukemia?

Short, Nicholas J ; Kantarjian, Hagop ; Jabbour, Elias ; Ravandi, Farhad

Best practice & research. Clinical haematology, 2017-09, Vol.30 (3), p.193-200 [Periódico revisado por pares]

Netherlands: Elsevier Ltd

Texto completo disponível

Citações Citado por
4
EXABS-135-ALL Novel Chemotherapy Can Eliminate the Need for Transplant in ALL
EXABS-135-ALL Novel Chemotherapy Can Eliminate the Need for Transplant in ALL
Material Type:
Artigo 		Adicionar ao Meu Espaço

EXABS-135-ALL Novel Chemotherapy Can Eliminate the Need for Transplant in ALL

Short, Nicholas J

Clinical lymphoma, myeloma and leukemia, 2022-10, Vol.22 Suppl 2, p.S44-S46 [Periódico revisado por pares]

United States

Texto completo disponível

Citações Citado por
5
SOHO State of the Art Updates and Next Questions, Measurable Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
SOHO State of the Art Updates and Next Questions, Measurable Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

SOHO State of the Art Updates and Next Questions, Measurable Residual Disease in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Short, Nicholas J. ; Jabbour, Elias ; Kantarjian, Hagop

Clinical lymphoma, myeloma and leukemia, 2024-07, Vol.24 (7), p.427-432 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
6
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study
Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Inotuzumab ozogamicin in combination with low-intensity chemotherapy for older patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia: a single-arm, phase 2 study

Kantarjian, Hagop ; Ravandi, Farhad ; Short, Nicholas J ; Huang, Xuelin ; Jain, Nitin ; Sasaki, Koji ; Daver, Naval ; Pemmaraju, Naveen ; Khoury, Joseph D ; Jorgensen, Jeffrey ; Alvarado, Yesid ; Konopleva, Marina ; Garcia-Manero, Guillermo ; Kadia, Tapan ; Yilmaz, Musa ; Bortakhur, Gautam ; Burger, Jan ; Kornblau, Steven ; Wierda, William ; DiNardo, Courtney ; Ferrajoli, Alessandra ; Jacob, Jovitta ; Garris, Rebecca ; O'Brien, Susan ; Jabbour, Elias

The lancet oncology, 2018-02, Vol.19 (2), p.240-248 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
7
SOHO State of the Art Updates & Next Questions: Intensive and Non–Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
SOHO State of the Art Updates & Next Questions: Intensive and Non–Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

SOHO State of the Art Updates & Next Questions: Intensive and Non–Intensive Approaches for Adults With Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia

Short, Nicholas J. ; Kantarjian, Hagop ; Jabbour, Elias

Clinical lymphoma, myeloma and leukemia, 2022-02, Vol.22 (2), p.61-66 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
8
Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past
Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past
Material Type:
Artigo 		Adicionar ao Meu Espaço

Using immunotherapy and novel trial designs to optimise front-line therapy in adult acute lymphoblastic leukaemia: breaking with the traditions of the past

Short, Nicholas J ; Kantarjian, Hagop

The Lancet. Haematology, 2023-05, Vol.10 (5), p.e382-e388 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por
9
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia
Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Choosing between intensive and less intensive front-line treatment approaches for older patients with newly diagnosed acute myeloid leukaemia

Short, Nicholas J ; Kantarjian, Hagop

The Lancet. Haematology, 2022-07, Vol.9 (7), p.e535-e545 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia
Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Safety and Efficacy of Blinatumomab in Combination With a Tyrosine Kinase Inhibitor for the Treatment of Relapsed Philadelphia Chromosome-positive Leukemia

Assi, Rita ; Kantarjian, Hagop ; Short, Nicholas J. ; Daver, Naval ; Takahashi, Koichi ; Garcia-Manero, Guillermo ; DiNardo, Courtney ; Burger, Jan ; Cortes, Jorge ; Jain, Nitin ; Wierda, William ; Chamoun, Salim ; Konopleva, Marina ; Jabbour, Elias

Clinical lymphoma, myeloma and leukemia, 2017-12, Vol.17 (12), p.897-901 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2016  (3)
  2. 2016Até2017  (7)
  3. 2018Até2019  (10)
  4. 2020Até2022  (35)
  5. Após 2022  (22)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.